These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
326 related items for PubMed ID: 9348444
1. Dietary glycine prevents increases in hepatocyte proliferation caused by the peroxisome proliferator WY-14,643. Rose ML, Germolec D, Arteel GE, Schoonhoven R, Thurman RG. Chem Res Toxicol; 1997 Oct; 10(10):1198-204. PubMed ID: 9348444 [Abstract] [Full Text] [Related]
2. Oxidants from nicotinamide adenine dinucleotide phosphate oxidase are involved in triggering cell proliferation in the liver due to peroxisome proliferators. Rusyn I, Yamashina S, Segal BH, Schoonhoven R, Holland SM, Cattley RC, Swenberg JA, Thurman RG. Cancer Res; 2000 Sep 01; 60(17):4798-803. PubMed ID: 10987289 [Abstract] [Full Text] [Related]
3. Relationship of hepatic peroxisome proliferation and replicative DNA synthesis to the hepatocarcinogenicity of the peroxisome proliferators di(2-ethylhexyl)phthalate and [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio]acetic acid (Wy-14,643) in rats. Marsman DS, Cattley RC, Conway JG, Popp JA. Cancer Res; 1988 Dec 01; 48(23):6739-44. PubMed ID: 3180084 [Abstract] [Full Text] [Related]
4. Differences between the promoting activities of the peroxisome proliferator WY-14,643 and phenobarbital in rat liver. Cattley RC, Popp JA. Cancer Res; 1989 Jun 15; 49(12):3246-51. PubMed ID: 2566380 [Abstract] [Full Text] [Related]
5. WY-14,643 induced cell proliferation and oxidative stress in mouse liver are independent of NADPH oxidase. Woods CG, Burns AM, Bradford BU, Ross PK, Kosyk O, Swenberg JA, Cunningham ML, Rusyn I. Toxicol Sci; 2007 Aug 15; 98(2):366-74. PubMed ID: 17483499 [Abstract] [Full Text] [Related]
14. Kupffer cell oxidant production is central to the mechanism of peroxisome proliferators. Rose ML, Rivera CA, Bradford BU, Graves LM, Cattley RC, Schoonhoven R, Swenberg JA, Thurman RG. Carcinogenesis; 1999 Jan 01; 20(1):27-33. PubMed ID: 9934846 [Abstract] [Full Text] [Related]
15. Inhibition of hepatocarcinogenesis by the deletion of the p50 subunit of NF-kappaB in mice administered the peroxisome proliferator Wy-14,643. Glauert HP, Eyigor A, Tharappel JC, Cooper S, Lee EY, Spear BT. Toxicol Sci; 2006 Apr 01; 90(2):331-6. PubMed ID: 16434500 [Abstract] [Full Text] [Related]
16. Antibodies to tumor necrosis factor alpha prevent increases in cell replication in liver due to the potent peroxisome proliferator, WY-14,643. Bojes HK, Germolec DR, Simeonova P, Bruccoleri A, Schoonhoven R, Luster MI, Thurman RG. Carcinogenesis; 1997 Apr 01; 18(4):669-74. PubMed ID: 9111198 [Abstract] [Full Text] [Related]
17. Dexamethasone selectively inhibits WY14,643-induced cell proliferation and not peroxisome proliferation in mice. Lawrence JW, Wollenberg GK, Frank JD, DeLuca JG. Toxicol Appl Pharmacol; 2001 Jan 15; 170(2):113-23. PubMed ID: 11162775 [Abstract] [Full Text] [Related]
18. Regulation of peroxisome proliferator-activated receptor-alpha mRNA in rat liver. Sterchele PF, Sun H, Peterson RE, Vanden Heuvel JP. Arch Biochem Biophys; 1996 Feb 15; 326(2):281-9. PubMed ID: 8611035 [Abstract] [Full Text] [Related]
19. Paradoxical increase in peroxisomal cyanide-insensitive respiration following dietary exposure to WY-14,643 in the perfused liver. Bojes HK, Sausen PJ, Cattley RC, Keller BJ, Thurman RG. Toxicol Appl Pharmacol; 1996 Apr 15; 137(2):202-9. PubMed ID: 8661345 [Abstract] [Full Text] [Related]
20. A comparison of liver protein changes in mice and hamsters treated with the peroxisome proliferator Wy-14,643. Giometti CS, Tollaksen SL, Liang X, Cunningham ML. Electrophoresis; 1998 Oct 15; 19(14):2498-505. PubMed ID: 9820974 [Abstract] [Full Text] [Related] Page: [Next] [New Search]